Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

AIM AIM ImmunoTech Inc

0,4099

-0,005 (-1,21%)

Zuletzt aktualisiert: 15:49:34

Verzögert um 15 Minuten

Form D/A - Notice of Exempt Offering of Securities: [Amend]

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more AIM ImmunoTech Charts.

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more AIM ImmunoTech Charts.

News AIM ImmunoTech Inc

AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
Montag 20 Mai 2024 (1 Tag vor) • GlobeNewswire Inc.

AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
Donnerstag 16 Mai 2024 (5 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 15 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast
Donnerstag 9 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
Montag 6 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
Montag 29 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Donnerstag 25 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Donnerstag 18 April 2024 (1 Monat vor) • GlobeNewswire Inc.

AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
Montag 15 April 2024 (1 Monat vor) • GlobeNewswire Inc.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Donnerstag 11 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Weitere AIM ImmunoTech Inc News-Artikel

Euro vs Sterling

Deutsche Lufthansa

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen